Trials / Completed
CompletedNCT01635010
Obstructive Sleep Apnea in the Absence of Metabolic Syndrome
Obstructive Sleep Apnea in the Absence of Metabolic Syndrome: Pulse Wave Velocity, Inflammatory and Oxidative Stress Markers
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 34 (actual)
- Sponsor
- Associação Fundo de Incentivo à Pesquisa · Academic / Other
- Sex
- Male
- Age
- 25 Years – 60 Years
- Healthy volunteers
- Accepted
Summary
Obstructive Sleep Apnea (OSA) is commonly associated with factors that increase cardiovascular risk, including Metabolic Syndrome (MS). There is a lack of well-controlled clinical studies investigating the independent effects of OSA in the development of cardiovascular disease, especially evaluating jointly mechanisms involved in these disorders such as inflammatory response, oxidative stress and vascular changes. The investigators hypothesized that in the absence of MetS, the mechanisms involved on cardiovascular consequences in OSA patients would be less important. The purpose of this study is to analyze the effects of OSA in the absence of MS, on inflammatory, oxidative stress and vascular markers; to verify the influence of excessive daytime sleepiness (EDS) on the same parameters; and additionally verify the effects of nasal continuous positive airway pressure (nCPAP)in theses parameters.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | continuous positive airway pressure (CPAP) | CPAP pressure is individually prescript according to polysomnography for CPAP titration |
Timeline
- Start date
- 2008-12-01
- Primary completion
- 2011-12-01
- Completion
- 2011-12-01
- First posted
- 2012-07-06
- Last updated
- 2012-07-06
Locations
1 site across 1 country: Brazil
Source: ClinicalTrials.gov record NCT01635010. Inclusion in this directory is not an endorsement.